Skip to main content
. 2021 Mar 21;73(6):1058–1065. doi: 10.1093/cid/ciab252

Table 2.

Participants Who Experienced WHO Stage 2, 3, or 4 Events or Death by Treatment Arm

Participants With Any Event Co-trimoxazole (n = 500), n (%) Chloroquine (n = 500), n (%) No Prophylaxis (n = 499), n (%) Total (N = 1499), n (%)
Adjudicated WHO stage 3+ event or deatha 48 (10) 62 (12) 60 (12) 170 (11)
WHO stage 2 event, adjudicated WHO stage 3+ event, or deathb 57 (11) 80 (16) 79 (16) 216 (14)

Column header counts and denominators are the number of randomized participants. Participants are included in each row if they had any event of that type. Abbreviation: WHO, World Health Organization.

aIncludes deaths not otherwise classified as a WHO stage 3+ event.

bInvestigator-reported WHO stage 2 events are included because WHO stage 2 events are not adjudicated. Deaths are included if not otherwise classified as a WHO stage 2 event per investigator or adjudicated WHO stage 3+ event.